Symptoms of Down syndrome are produced by gene impairments across every chromosome, not just one, according to a study that may bring new understanding to the most common genetic cause of intellectual disability.
Nordic Capital, a Stockholm-based private-equity firm, is leading bidders for LTS Lohmann Therapie-Systeme AG, which would end a nearly yearlong attempt to sell the German nicotine-patch maker, people with knowledge of the matter said.
Former SAC Capital Advisors LP fund manager Mathew Martoma’s securities fraud convictions should stand and he shouldn’t get a new trial for the most lucrative insider-trading scheme ever, U.S. prosecutors said.
SAC Capital Advisors LP’s plea agreement to pay a $900 million penalty should be accepted, U.S. prosecutors told a judge as they seek the biggest criminal fine ever imposed for insider trading following a six-year probe of the firm.
Prana Biotechnology Ltd. plunged as much as 76 percent in trading before U.S. exchanges opened after the company’s experimental drug for Alzheimer’s disease failed to help patients in a clinical trial.
Alzheimer’s, known mostly for the memory loss and confusion it causes, may be the nation’s third- most deadly killer, according to a study that suggests many more Americans die from the disease than is known.
Scientists have discovered that a gene-regulating protein that protects the developing brain of a fetus resurfaces in old age and may stave off dementia, a finding that could open a new path in Alzheimer’s research.